RNA Formulation Solutions
-
CD34+ HSC LNP Kits
4/24/2025
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
-
in vivo-jetRNA®+
9/14/2022
Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results
in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry. -
Delivering Best-In-Class Nanoparticles
6/30/2025
Achieve uniformity and control in nanoparticle synthesis with an advanced system that streamlines production, reduces human intervention, and delivers exceptional particle characteristics for diverse applications.
-
Customized Skid For Large Production Scale: IJM NanoProducer
12/9/2024
The Impingement Jets Mixing (IJM) Large Production Scale Units are designed for high-flow production of nanoparticles (LNP, micro-emulsions, etc) and can be configured with up to eight parallel mixing units depending on customer requirements.
-
Oligonucleotides & Peptides
Our expert team of 120 process chemists and 50 analytical chemists deliver process chemistry experience, formulation, analytical expertise and regulatory insight to meet your oligonucleotide and peptide needs.
-
Accelerating Gene Therapy With The HIT SCAN Platform
4/7/2025
Battelle’s HIT SCAN™ platform accelerates gene therapy by using high-throughput methods to design, screen, and optimize polymer nanoparticles (PNPs) for effective, non-viral delivery.
-
NanoImprove The Performance Of Your Biologic Formulation
11/20/2025
Unlock superior performance for peptides and proteins using nanotechnology. Achieve high drug loads for subcutaneous delivery and stable, aerodynamic dry powders for deep-lung inhalation.
-
Contract Services To Optimize Continuous Nanoparticle Processing
10/16/2025
DIANT Pharma provides continuous manufacturing systems and technical services for nanoparticle-based formulations. The company’s platform supports both research and manufacturing teams working on lipid nanoparticles (LNPs), liposomes, polymeric micelles, nucleic acid–lipid complexes, and other colloidal systems.
-
Labscale Lipid Nanoparticle Production: IJM NanoScaler
12/9/2024
The benchtop IJM NanoScaler system is designed for lipid nanoparticle R&D – allowing scientists to screen for the optimal process parameters for the formulation of API-containing lipid nanoparticles.
-
Automated, Single-Use System For Clinical And Commercial LNP Production
7/21/2023
The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions. Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.